Steakholder Foods Ltd. · NASDAQ:STKH
Steakholder Foods — MeaTech 3D — Investor Presentation (June 2022)
23 slides from Steakholder Foods's investor presentation, Jun 29, 2022
Slide 1: Pioneering Meat 2.0 Investor Presentation June 2022
PIONEERING MEAT 2 . 0 TM TM Investor Presentation june 2022
Slide 2: Forward-looking statements disclaimer
This presentation and oral statements made regarding the subject of this presentation contain “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. Such statements include, without limitation, re
Slide 3: Our Leadership Team
Our Leadership Team ARIK KAUFMAN Co-Founder & CEO Arik Kaufman has founded various Nasdaq and TASE traded food-tech firms. He is a founding partner of the BlueSoundWaves collective led by Ashton Kutcher, Guy Oseary and Effie Epstein. Mr. Kaufman has extensive experience in food-tech and biotech law,
Slide 4: MeaTech Highlights
MeaTech Highlights 2019 Initiated activities June 2022: $52.4M RAISED, 65+ EMPLOYEES, 15 PATENT APPLICATIONS (one granted) 2022 Reported promising results with muscle stem cell differentiation into muscle fibers that better resemble whole cuts of meat Expanded into the US Construction expected to co
Slide 5: Alternative Protein Market Overview
Alternative Protein Market Overview
Slide 6: Evolving Alt-Meat Landscape
COMPLEXITY ORGANOLEPTIC PROPERTIES Plant-based alternative meat Cultivated hybrid meat1 TODAY NASCENT Cultivated whole-cut premium meat BLEEDING EDGE EVOLVING ALT-MEAT LANDSCAPE Thin tissue of premium cultivated meat Note: 1 We define this category as hybrid food with up to 50% of cultivated meat in
Slide 7: First stop: Combining Both Worlds, Cultured and Plant-Based: Hybrid Meats
First stop: COMBINING Both Worlds CULTURED and PLANT-BASED: HYBRID MEATS
Slide 8: MeaTech's Go To Market Strategy: Starting with Hybrid Products
MEATECH’S GO TO MARKET STRATEGY: STARTING WITH HYBRID PRODUCTS Making strategic acquisitions in the cultivated meat sector, including our acquisition of Belgium-based ‘Peace of Meat’ in Q1 2021. Focusing on improving the taste, texture and nutritional value of plant-based and cell-based proteins. We
Slide 9: MeaTech: Printing Real Meat
MeaTech’ PRINTING REAL MEAT
Slide 10: Our Commitment to Sustainable Development Goals
Our commitment To Sustainable Development Goals We have identified areas where MeaTech has the most potential to contribute to the achievement of the UN Sustainable Development Goals and have aligned our business strategy to promote long-term sustainability. Similarly, as a United Nations Global Com
Slide 11: The Impact of Cultivated Meat
THE IMPACT OF CULTIVATED MEAT ENVIRONMENTAL IMPACT* POTENTIAL ADVANTAGES FOR THE MEAT INDUSTRYTHROUGH THE ALIGNMENT WITH ESG CRITERIA IN A CIRCULAR ECONOMY Up to 78% less freshwater use Up to 95% less land use Up to 93% less air pollution SOCIAL IMPACT Controlled, sterile production environment desi
Slide 12: MeaTech Strategy & Business Model
Meatech Strategy & Business Model
Slide 13: Our Planned Go To Market Model
Our planned Go To Market model Cultivated meat biomass B2B Final product elaboration Structured cultivated meat products Unstructured cultivated meat products Producing cells at scale to make fat and protein biomass for use in end products Selling MeaTech’s ingredients as B2B products Using cell-bas
Slide 14: Competitive Landscape
Company Value (USD) Total Funding Amount (USD) 3D Printing Non-GMO Cell Lines Structured meat Ground Products Chicken Beef Pork Fish MeaTech 3D Ltd. Public 54.3 M 52.4 M Eat Just- Good Meat 1B 267 M Upside Food 1B 606 M Mosa Meat 300-500M 96 M Blue Nalu 300-500M 84.8 M Future Meat Technologies 900M
Slide 15: Technology Overview
Technology Overview
Slide 16: Meet our R&D team leaders
Meet our R&D team leaders Tal KalksteinSoftware Manager Timofey Shmal3D Printing Expert Dr. Nadav NoorTissue Engineering & Bio-Printing Expert Nelly Komarovsky Gulman Mass Production Manager Daria PetrovCell Isolation & Characterization Manager Dr. Yoni Moskovitz Cellular Engineering Manager Shahar
Slide 17: MeaTech's Core R&D Technology
HIGH THROUGHPUT 3D TISSUE ENGINEERING 3D PRINTING AND INCUBATION Scaffold materials Bio-ink formulations Software development Note: These images are computer generated and represent future expectations. MEATECH’S CORE R&D Technology MULTI-SPECIES CELL-BASED MANUFACTURING WITH BIOREACTOR SYSTEMS & PR
Slide 18: MeaTech's Cell-Based Process Vision
CELL COLLECTION CELL GROWTH Upon reaching sufficient cell quantities, stem cells are differentiated into fat and muscle cells. GROUND PRODUCTS Cell lines are developed to reliably express certain characteristics. Stem cells are transferred to bioreactors for exponential growth under ideal conditions
Slide 19: MeaTech's Cultured Steak Vision
MEATECH'S CULTURED STEAK VISION A FLEXIBLE MANUFACTURING PROCESS FOR 3D-PRINTED TISSUE BIO-INKS 3D BIOPRINTING INCUBATION STRUCTURED MEAT Bio-inks formulated from our cell lines and unique scaffolding materials are loaded into our 3D bioprinter. Bio-inks are accurately printed and cells are assemble
Slide 20: MeaTech's IP
MEATECH’S IP 15 PATENT APPLICATIONS SUBMITTED, 1 GRANTED, 6 TRADE SECRETS IDENTIFIED AND PRESERVED Cultivated Edible Meat Fabrication Using Bioprinting Harvesting Bovine Embryonic Inner Cell Mass Physical Manipulation of Cultivated Tissue Bioprinter Printhead Design Growth Support For Cell Culture B
Slide 21: Thank You!
THANK YOU! WWW.MEATECH3D.COM No Animals Were Harmed in the Making of This Slide deck
Slide 22: Appendices
Appendices
Slide 23: Appendix - Balance Sheet
Appendix - Balance Sheet ($, millions) 31-03-2022 31-12-2021 Current Assets 16.9 22.1 Non-Current Assets 23.2 18.5 Total Assets 40.1 40.7 Current Liabilities 3.9 2.8 Non-Current Liabilities 3.6 0.2 Total Liabilities 7.5 3.0 Total Equity 32.6 37.6 Total Liabilities And Equity 40.1 40.7 SOLID BALANCE